GSK plcGSKNYSE
Loading
P/E Ratio: Discounted ValuationCompressed
Percentile Rank57
3Y CAGR+49.5%
5Y CAGR+6.6%
Year-over-Year Change
Price-to-earnings ratio
3Y CAGR
+49.5%/yr
vs -30.2%/yr prior
5Y CAGR
+6.6%/yr
Recent acceleration
Acceleration
+79.7pp
Accelerating
Percentile
P57
Within normal range
vs 5Y Ago
1.4x
Solid growth
Streak
1 yr
Consecutive declineCompressed
| Period | Value | YoY Change |
|---|---|---|
| 2025 | 12.93 | -39.3% |
| 2024 | 21.32 | +78.8% |
| 2023 | 11.92 | +208.1% |
| 2022 | 3.87 | -67.3% |
| 2021 | 11.85 | +26.3% |
| 2020 | 9.39 | -38.7% |
| 2019 | 15.31 | -6.3% |
| 2018 | 16.34 | -52.0% |
| 2017 | 34.08 | -49.3% |
| 2016 | 67.26 | - |